LYOCONTRACT Invests in the Future of Sterile Manufacturing

LYOCONTRACT is expanding its sterile manufacturing capabilities with a new state-of-the-art production facility and Annex 1-compliant aseptic filling line to support future customer demand.

LYOCONTRACT has started the construction of a new production facility to significantly expand its sterile manufacturing capacity. The investment includes a state-of-the-art Annex 1-compliant aseptic filling line with isolator technology and advanced lyophilization capabilities. The expansion strengthens our ability to support pharmaceutical and biotech companies from clinical development through commercial manufacturing while ensuring the highest GMP quality standards.